Non-alcoholic steatohepatitis disease progression in participants from the United States TARGET-NASH real world longitudinal observational study

被引：0
|
作者：
Sartini, Claudio [1 ]
Rudolph, Bryan [1 ]
Fraessdorf, Mandy [2 ]
Morris, Heather [3 ]
Gazis, Derek [3 ]
Mospan, Andrea [3 ]
Fried, Michael [3 ]
Roden, Michael [4 ]
Tetri, Brent [5 ]
Cusi, Kenneth [6 ]
Newsome, Philip N. [7 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA
[2] Boehringer Ingelheim GmbH & Co KG, Frankfurt, Germany
[3] Target RWE, Durham, NC USA
[4] German Diabet Ctr, Hamburg, Germany
[5] St Louis Univ, St Louis, MO USA
[6] Univ Florida, Gainesville, FL 32611 USA
[7] Univ Birmingham, Birmingham, W Midlands, England
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS-089
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
  • [2] ECONOMIC BURDEN OF PROGRESSION TO CIRRHOSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES
    Patil, D.
    Qiu, Y.
    Kou, T. D.
    Myers, J.
    Burns, L.
    VALUE IN HEALTH, 2019, 22 : S179 - S179
  • [3] Economic Burden of Progression to Cirrhosis in Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
    Patil, Dhaval
    Qiu, Ying
    Kou, Tzuyung
    Myers, Joel
    Nandal, Aditya
    Burns, Leah
    HEPATOLOGY, 2018, 68 : 435A - 435A
  • [4] THE VALUE OF CURING ADVANCED NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES
    Younossi, Zobair M.
    Tampi, Radhika
    Nader, Fatema
    Younossi, Issah M.
    Cable, Rebecca
    Srishord, Manirath K.
    Racila, Andrei
    GASTROENTEROLOGY, 2019, 156 (06) : S1234 - S1234
  • [5] Components of Metabolic Syndrome and the Rising Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States
    Stepanova, Maria
    Afendy, Mariam
    Vernon, Gregory C.
    Nader, Fatema
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2011, 140 (05) : S988 - S988
  • [6] Non-Alcoholic Steatohepatitis (NASH) Influences the Disease Progression of Chronic Hepatitis C
    Matsumoto, T.
    Ogura, K.
    MODERN PATHOLOGY, 2012, 25 : 419A - 419A
  • [7] Non-Alcoholic Steatohepatitis (NASH) Influences the Disease Progression of Chronic Hepatitis C
    Matsumoto, T.
    Ogura, K.
    LABORATORY INVESTIGATION, 2012, 92 : 419A - 419A
  • [8] DIAGNOSTIC TESTING FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS SPECIALTY, COMORBIDITY, AND FIBROSIS STAGE: A REAL-WORLD ASSESSMENT IN THE UNITED STATES
    Shinde, Shraddha
    Schapiro, David
    Leith, Andrea
    Johnson, William
    Mascia, Daniel
    Higgins, Victoria
    Hartman, Mark
    HEPATOLOGY, 2022, 76 : S638 - S639
  • [9] Burden of Illness Economic Model for Patients with Non-alcoholic Steatohepatitis (NASH) in the United States
    Younossi, Zobair M.
    Priyadarshini, Masoom
    Afendy, Mariam
    Nader, Fatema
    Younossi, Issah
    Racila, Andrei
    Stepanova, Maria
    HEPATOLOGY, 2017, 66 : 1115A - 1116A
  • [10] LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION
    Lai, M.
    Frick, A.
    Haubrich, R.
    Koch, B.
    Milligan, S.
    Natha, M.
    Radtchenko, J.
    Younossi, Z.
    Afdhal, N.
    VALUE IN HEALTH, 2020, 23 : S143 - S143
12345